HB2106
Health insurance; prohibits pharmacy override for enrollee with sickle cell disease.
Summary
As Introduced. Health insurance; pharmacy override for enrollee with sickle cell disease; prohibited.
Prohibits a health insurance carrier from requiring a pharmacy to override a denial code or to request an override in order to dispense a prescription drug for the treatment or management of pain to an enrollee who has been diagnosed with sickle cell disease.-
Bill History
- 01/07/2025 - House: Prefiled and ordered printed; Offered 01-13-2025 25101618D
- 01/07/2025 - House: Referred to Committee on Labor and Commerce
- 01/14/2025 - House: Assigned L & C sub: Subcommittee #1
- 01/20/2025 - House: Placed on Labor and Commerce Agenda
- 01/21/2025 - House: Subcommittee recommends laying on the table (4-Y 3-N)
- 02/05/2025 - House: Left in Labor and Commerce
